Written by: Chaz Faulhaber
Published: February 12, 2026
Wellness

Onus IV Therapy + Longevity Joins the American Peptide Association: Advancing Access to GLP-1, GIP+GLP-1, and Sermorelin Therapies

Onus IV Therapy + Longevity Joins the American Peptide Association

Onus IV Therapy + Longevity is proud to announce its official membership in the American Peptide Association (APA), reinforcing its commitment to advancing safe, evidence-based peptide therapies. This milestone reflects Onus’ leadership in delivering cutting-edge treatments, including GLP-1 therapy, GIP+GLP-1 dual agonist therapy, and Sermorelin therapy, to patients seeking improved metabolic health, optimized body composition, and enhanced longevity.

As peptide therapies continue to transform modern medicine, Onus IV Therapy + Longevity remains at the forefront—providing patients with access to clinically guided, physician-supervised protocols rooted in science, safety, and measurable outcomes.

https://www.onusiv.com/images/uploads/group-of-vaccine-bottles-medicine-in-ampoules-gl-2026-01-08-05-43-47-utc.jpg

What the American Peptide Association Represents

The American Peptide Association is a leading organization dedicated to:

  • Promoting ethical, research-driven peptide therapies

  • Establishing best practices and safety standards

  • Supporting clinical innovation in longevity and metabolic medicine

  • Acting as a bridge organization between providers and state regulators

By joining the APA, Onus IV Therapy + Longevity aligns with the highest standards of peptide medicine and demonstrates its commitment to responsible leadership in this rapidly evolving field.

Sermorelin Therapy: Supporting Natural Growth Hormone Production and Longevity

Sermorelin works by stimulating the body’s natural production of growth hormone, supporting regeneration, recovery, and long-term vitality. Sermorelin therapy is one of the most established and well-researched peptide treatments in longevity medicine.

Benefits of Sermorelin therapy include:

  • Improved recovery and tissue repair

  • Support for lean muscle maintenance

  • Enhanced sleep quality

  • Improved energy levels

  • Support for healthy aging and longevity

Unlike direct hormone replacement, Sermorelin supports the body’s natural regulatory pathways, making it a foundational therapy in modern longevity protocols.

Hero.jpg

Expanding Access to GLP-1 Therapy for Metabolic Health and Weight Management

GLP-1 (Glucagon-Like Peptide-1) therapies have emerged as one of the most impactful advancements in metabolic medicine. These GLP-1's work by supporting and enabling the body’s natural metabolic processes, helping regulate appetite, insulin sensitivity, and energy utilization. It's a little like setting up additional cell phone towers so that your body can communicate more efficiently. 

Key benefits of GLP-1 therapy include:

  • Improved metabolic efficiency

  • Sustainable weight loss support (medically guided at Onus by a nurse practitioner)

  • Enhanced insulin sensitivity

  • Reduced appetite and improved satiety signaling

  • Support for long-term metabolic health

GLP-1's have fundamentally shifted the landscape of weight management, offering a medical solution that addresses underlying metabolic signaling—not just their symptoms. Combining this with our comprehensive longevity focus towards helping our clients Live Better, Longer, and you'll see why our GLP-1 program leads the way in helping clients achieve their goals.

Onus---Banner.jpg

Leading Innovation with GIP+GLP-1 Dual Agonist Therapy

Second Generation treatments combining GIP (Glucose-Dependent Insulinotropic Polypeptide) and GLP-1 receptor agonists represent a significant advancement beyond GLP-1's alone. It's  These dual-pathway peptides work synergistically to improve metabolic regulation, energy balance, and body composition, with some side effects less pronounced, or mitigated entirely. Everyone's body is different, and as your access to these treatments grows, discussing which outcomes would best suit your needs with our qualified medical team will help determine your best outcome!

Benefits of GIP+GLP-1 therapy include:

  • Enhanced metabolic signaling compared to GLP-1 alone (some clients may see greater weight reduction over time)

  • Greater support for fat loss while preserving lean tissue

  • Improved glucose regulation

  • Increased metabolic flexibility

  • Potential improvements in energy and recovery (when tailored appropriately with our Nurse Practitioners)

GIP+GLP-1 therapies represent the next wave of metabolic optimization, offering patients more advanced tools to improve their health trajectory. As a member of the American Peptide Association, Onus IV Therapy + Longevity remains committed to delivering these therapies responsibly under medicaly guided supervision.

Onus_iv_Peptides+-172_copy.jpg

The Future of Peptide Therapy and Longevity Medicine

Peptide therapies are rapidly reshaping the future of medicine, particularly in the areas of metabolic health, weight optimization, and healthy aging. Therapies such as GLP-1, GIP+GLP-1 dual agonists, and Sermorelin represent a shift toward precision medicine—targeting biological signaling pathways to restore optimal function.

As research continues to advance, organizations like the American Peptide Association play a critical role in ensuring these therapies remain safe, effective, and accessible.

Onus IV Therapy + Longevity is proud to contribute to this mission.

Back to all Posts
Share this post
Written by:
Chaz Faulhaber

Chaz Faulhaber is the co-owner and co-founder of Onus IV. He’s an avid mountain biker that has been immersed in the world of outdoor adventure, marketing, wellness, and brand management for over 10 years.